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The incidence of cerebral glioma in the working population: a forgotten
cancer?
R Grant1, D Collie 2 and C Counsell'
Departments of 'Clinical Neurosciences and 2Radiology, Western General Hospital, Edinburgh EH4 2XU, UK.
Summary We studied the incidence of intracranial tumours in Lothian Region in south-east Scotland in
1989-90. Among 106 patients resident in the Region, 60 (57%) were of working age (15-64 years). All but
two cases (97%) were histologically confirmed. The average annual incidence of cerebral glioma in this age
range was 5.9 (95% CI 3.8-8.0) per 100 000 per year. Cerebral glioma will affect approximately 2100 people of
working age in the UK every year.
Keywords: incidence; glioma; epidemiology
Cancer is the leading cause of death in people under 65 years
of age in Scotland (The Scottish Office, Home and Health
Department, 1991). In 1992 a government policy document
proposed targeting patients under the age of 65 years to
reduce cancer deaths by 15% by the year 2000 (Scottish
Office, Home and Health Department, 1993). To achieve this
aim, an advisory committee was established and nine
common cancers were selected for special attention (breast,
lung, colon, bladder, prostate, ovary, cervix, uterus and
stomach) (Aitken et al., 1994). Brain tumours were not
included.
There are no up-to-date UK incidence figures for cerebral
glioma in the adult population of working age. The
commonly quoted average annual incidence of 3.94 per
100 000 population per year was estimated at a time when
computerised tomographic (CT) scanning was not available
(1965-74), and was based on referrals to a specialist regional
neuroscience unit (Barker et al., 1976).
We report the incidence of cerebral glioma in patients aged
15-64 years resident in Lothian Region as part of a more
extensive audit of all incident cases of any intracranial
tumour in south-east Scotland diagnosed between January
1989 and December 1990.
Materials and methods
Patients with an intracranial tumour were defined as incident
cases if the first CT scan suggestive of tumour was performed
between 1 January 1989 and 31 December 1990. Patients with
cerebral glioma were defined as those who had either
histological confirmation or a CT scan and clinical course
compatible with glioma. Patients with histological evidence of
medulloblastoma/primitive neuroectodermal tumour, cranio-
pharyngioma, primary CNS lymphoma or metastasis were
excluded. For the purposes of this report, cases were
restricted to those aged 15-64 at the time of the first
abnormal CT scan.
Case ascertainment
Incident cases were identified by examining all cranial CT
scan reports from 1 January 1989 to 31 December 1990,
from the three head CT scanners covering south-east
Scotland (Lothian Region, South Fife Region, East Central
Region, and the Borders Region; Figure 1). All three CT
scanners were situated within the geographical boundaries of
Lothian Region. Magnetic resonance imaging was also
available in Edinburgh in the years under study, but was
not the initial diagnostic investigation in any patient.
Analysis was restricted to cases resident in Lothian Region
only (EH post code). The nearest CT scanners outside
Lothian Region were situated in Glasgow, Dundee and
Newcastle (nearest approximately 40 miles from Lothian
boundary).
When there was any mention of an intracranial tumour on
the CT scan report, case records were examined. Any case
with a CT scan suggestive of intracranial tumour before 1
January 1989 was excluded. Cases with radiological diagnosis
of glioma were included, even though histology was not
obtained. Neuropathology reports on all brain specimens
from 1 January 1989 to 31 December 1993 were searched for
patients who had presented in the 2 years under study.
Neurology, neurosurgery, neuro-oncology, and endocrine
databases in Lothian were searched for patients presenting
in 1989 and 1990. Case records of all patients who had
cranial irradiation from January 1989 and 30 April 1991 were
searched as a further check.
Case records were traced by an audit assistant, but all
clinical information was gathered by experienced medical
staff. Personal and clinical information including impairment/
disability at presentation, treatment and the date of death
were recorded.
The resident population of Lothian Region was taken as
the average of the mid-year 1989 and 1990 estimates based on
the 1991 Census (K Dargie, GRO Scotland, personal
communication). There were an estimated 507 212 residents
in Lothian aged between 15-64 years.
Results
The audit identified a total of 579 incident cases of
intracranial tumour in the 2 years 1989-90 in south-east
Scotland. Of these, 153 (18.3%) were patients with cerebral
glioma. A total of 106 (69.3%) of these patients were from
Lothian Region (EH post code) and 60 patients (57%) were
aged between 15-64 years. Fifty-eight patients (97%) had
histological confirmation of the diagnosis; one patient with a
CT diagnosis of a low-grade glioma was still alive at 31
December 1993, and another, whose CT scan was consistent
with glioblastoma multiforme, had a poor performance status
at diagnosis and died 57 days after her CT scan.
The average annual incidence of cerebral glioma in the
15-64 year age range in Lothian Region was 5.9 per 100 000
per year (95% CI 3.8-8.0). Age-specific incidence rates are
shown in Table 1.
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Figure 1 Catchment area covered in audit ofany intracranial tumour in SE Scotland (Lothian, South Fife, East Central and Borders
Regions) (M). Incidence data on Lothian Region only (_)-population aged between 15 and 64= 507212.
Table 1 Cerebral glioma, Lothian Region, 1989-90: mean annual
age-specific incidence rates, 15-64 years
No. of Resident Incidence (95% CI) per
Age (years) patients population 100 000 per year
15-19 0 53243 0
20-29 12 136 244 4.4 (1.9-6.4)
30-39 8 108 120 3.7 (1.1-6.2)
40-49 15 93 586 8.0 (4.0-12.0)
50-59 16 78 666 10.2 (3.1-17.2)
60-64 9 37 354 12.0 (4.2-19.9)
Discussion
Brain tumours are perceived by oncologists as uncommon,
yet the most recent figures for cancer registration in Scotland
demonstrate that brain tumours are the eighth most common
malignancy under the age of 65, the fourth most common
under 45 and the most common solid malignancy in children
(Black et al., 1993; Sharp et al., 1993).
We found that the average annual incidence for cerebral
glioma in the population of working age was 5.9 per 100 000,
with the highest incidence in the 60-64 age group (12.0 per
100 000). Barker reported the incidence of adult glioma (over
the age of 15 years) in Southern England as 3.9 per 100 000
per year (Barker et al., 1976), and this figure is still
commonly cited in recent editions of UK textbooks on
neuro-oncology (McKeran et al., 1990). The lower incidence
rate could be accounted for by the single institution nature of
the earlier study and the fact that it was in pre-CT scanning
days. Average annual incidence rates of brain tumours (ICD-
191) at all ages in England and Wales between 1981 and 1984
are reported as 3.60 per 100 000 for males and 5.25 per
100 000 for females (Ben Shlomo and Davey Smith, 1989).
Some 62% of the population are in the working age range
(males 16-64, females 16-59) (K Dargie, personal commu-
nication). Based on an incidence rate of 5.9 per 100 000 per
year and a UK population of 57.41 million, one would expect
about 2100 new cases of cerebral glioma each year in the
population of working age.
The high incidence of glioma reported here is likely to be
due in part to better ascertainment of cases. It could also be
due either to a genuinely higher regional incidence in Lothian
or to an increase in incidence of glioma over the last two
decades. There does appear to have been an increase of 1-
2% a year in the incidence of brain tumours over the past 30
years in many countries (Muir et al., 1994), and this increase
may be significantly higher in the elderly (Greig et al., 1990).
The extent to which these increases in incidence are due to
improved case ascertainment remains uncertain.
Cancer co-ordinating bodies may not perceive cerebral
glioma as a common cancer in the working population
because, at present, even in a centre with a specialist
interest in neuro-oncology, only two-thirds of patients
receive cranial irradiation and only one in six receives
chemotherapy. Glioma is a common cause of cancer death
in the working population. Malignant brain tumours rank
as the fifth most common cause of death from solid
malignancy under the age of 65 years, only cancers of the
lung, breast, colon and oesophagus being more common. As
a cause of death in this age group, they are slightly more
common than cancers of the stomach, pancreas and ovary,
twice as common as cervical or bladder carcinoma, and
three times as common as prostatic carcinoma (Registrar
General for Scotland, 1993). Malignant brain tumours
account for 10.7% of all registered deaths from cancer in
people aged under 45.
Although gliomas are considered highly resistant to
radiation therapy or chemotherapy, there is no doubt that
younger patients are more likely to respond to these
modalities, and treatment can result in survival gains.
While better and less toxic treatments must be pursued, it
is also important to ensure that appropriate patients are
referred and treated promptly. If the aim of reducing
mortality from cancer under the age of 65 years is to be
achieved, primary brain tumours should not be forgotten by
national cancer advisory services (Aitken et al., 1994).
Clinical services in neuro-oncology should be co-ordinated
at a national and regional level if any progress in reducing
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